A carregar...
Therapeutic approach to treating patients with BRAF-mutant lung cancer: latest evidence and clinical implications
Lung adenocarcinoma is known for its high rate of somatic mutations and genomic rearrangements. The identification of epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements that sensitize tumors to specific drugs has changed the therapeutic approach and...
Na minha lista:
| Publicado no: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5298452/ https://ncbi.nlm.nih.gov/pubmed/28203297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834016670555 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|